Redmile Group as of June 30, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 86 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fate Therapeutics (FATE) | 16.6 | $1.1B | 13M | 86.79 | |
| Igm Biosciences (IGMS) | 4.2 | $285M | 3.4M | 83.20 | |
| Beam Therapeutics (BEAM) | 3.9 | $264M | 2.1M | 128.71 | |
| Argenx Se Sponsored Adr (ARGX) | 3.5 | $238M | 790k | 301.07 | |
| Amicus Therapeutics (FOLD) | 3.0 | $201M | 21M | 9.64 | |
| Allakos (ALLK) | 2.8 | $189M | 2.2M | 85.37 | |
| Adc Therapeutics Sa SHS (ADCT) | 2.7 | $183M | 7.5M | 24.35 | |
| Shattuck Labs (STTK) | 2.4 | $163M | 5.6M | 28.99 | |
| Replimune Group (REPL) | 2.4 | $161M | 4.2M | 38.42 | |
| Invitae (NVTAQ) | 2.3 | $157M | 4.6M | 33.73 | |
| Deciphera Pharmaceuticals (DCPH) | 2.3 | $155M | 4.2M | 36.61 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.3 | $153M | 860k | 177.64 | |
| Medavail Holdings Ord | 2.1 | $144M | 12M | 12.25 | |
| Krystal Biotech (KRYS) | 2.1 | $141M | 2.1M | 68.00 | |
| Oak Street Health | 2.0 | $135M | 2.3M | 58.57 | |
| Kymera Therapeutics (KYMR) | 1.8 | $123M | 2.5M | 48.50 | |
| Seagen | 1.8 | $122M | 771k | 157.88 | |
| Verve Therapeutics (VERV) | 1.7 | $117M | 1.9M | 60.25 | |
| The Beauty Health Company Com Cl A (SKIN) | 1.6 | $107M | 6.4M | 16.80 | |
| Celldex Therapeutics Com New (CLDX) | 1.5 | $101M | 3.0M | 33.44 | |
| Atara Biotherapeutics (ATRA) | 1.5 | $100M | 6.4M | 15.55 | |
| Nevro (NVRO) | 1.5 | $99M | 595k | 165.79 | |
| Dex (DXCM) | 1.5 | $98M | 231k | 427.00 | |
| Livanova SHS (LIVN) | 1.4 | $94M | 1.1M | 84.11 | |
| Pliant Therapeutics (PLRX) | 1.4 | $92M | 3.2M | 29.12 | |
| Nurix Therapeutics (NRIX) | 1.3 | $85M | 3.2M | 26.53 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $83M | 2.1M | 38.85 | |
| Stoke Therapeutics (STOK) | 1.2 | $83M | 2.5M | 33.66 | |
| Repare Therapeutics Ord (RPTX) | 1.2 | $82M | 2.6M | 31.18 | |
| Annexon (ANNX) | 1.1 | $77M | 3.4M | 22.51 | |
| Epizyme | 1.0 | $71M | 8.5M | 8.31 | |
| Akero Therapeutics (AKRO) | 1.0 | $70M | 2.8M | 24.81 | |
| Scholar Rock Hldg Corp (SRRK) | 1.0 | $67M | 2.3M | 28.90 | |
| Prothena Corp SHS (PRTA) | 0.9 | $63M | 1.2M | 51.41 | |
| Zymergen | 0.9 | $61M | 1.5M | 40.01 | |
| ImmunoGen | 0.9 | $59M | 8.9M | 6.59 | |
| 1life Healthcare | 0.8 | $55M | 1.7M | 33.06 | |
| Ngm Biopharmaceuticals (NGM) | 0.8 | $55M | 2.8M | 19.72 | |
| Tcr2 Therapeutics Inc cs | 0.8 | $53M | 3.2M | 16.41 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.7 | $50M | 1.2M | 40.83 | |
| Alx Oncology Hldgs (ALXO) | 0.7 | $50M | 914k | 54.68 | |
| Selectquote Ord (SLQT) | 0.7 | $47M | 2.4M | 19.26 | |
| ICU Medical, Incorporated (ICUI) | 0.7 | $46M | 223k | 205.80 | |
| Nuvation Bio Com Cl A (NUVB) | 0.6 | $42M | 4.5M | 9.31 | |
| Anthem (ELV) | 0.6 | $42M | 109k | 381.80 | |
| Charles River Laboratories (CRL) | 0.6 | $40M | 108k | 369.92 | |
| Cigna Corp (CI) | 0.6 | $38M | 160k | 237.07 | |
| UnitedHealth (UNH) | 0.6 | $38M | 95k | 400.44 | |
| Neoleukin Therapeutics | 0.5 | $36M | 3.9M | 9.23 | |
| Lifestance Health Group (LFST) | 0.5 | $35M | 1.3M | 27.86 | |
| Catalent (CTLT) | 0.5 | $34M | 310k | 108.12 | |
| Zymeworks | 0.5 | $33M | 940k | 34.69 | |
| Amedisys (AMED) | 0.5 | $32M | 133k | 244.93 | |
| Allovir (ALVR) | 0.5 | $31M | 1.6M | 19.74 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.5 | $31M | 2.8M | 10.88 | |
| Avita Therapeutics (RCEL) | 0.4 | $29M | 1.4M | 20.52 | |
| Ardelyx (ARDX) | 0.4 | $28M | 3.7M | 7.58 | |
| Bioventus Com Cl A (BVS) | 0.4 | $26M | 1.5M | 17.60 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $23M | 426k | 53.20 | |
| Immatics SHS (IMTX) | 0.3 | $23M | 1.9M | 11.61 | |
| Ppd | 0.3 | $22M | 467k | 46.09 | |
| Atreca Cl A Com (BCEL) | 0.3 | $21M | 2.5M | 8.52 | |
| Quantum Si Com Cl A (QSI) | 0.3 | $21M | 1.7M | 12.26 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $20M | 2.1M | 9.79 | |
| Gritstone Oncology Ord (GRTS) | 0.3 | $20M | 2.2M | 9.13 | |
| Itamar Med Sponsored Ads | 0.3 | $20M | 855k | 23.55 | |
| Dynamics Special Purpose Cor Class A Com | 0.3 | $20M | 2.0M | 9.94 | |
| Innovage Hldg Corp (INNV) | 0.3 | $18M | 844k | 21.31 | |
| Stereotaxis Com New (STXS) | 0.3 | $18M | 1.9M | 9.64 | |
| Alpha Teknova (TKNO) | 0.3 | $17M | 725k | 23.73 | |
| Hookipa Pharma Inc equity (HOOK) | 0.3 | $17M | 1.9M | 9.16 | |
| Quanterix Ord (QTRX) | 0.2 | $14M | 241k | 58.66 | |
| Profound Med Corp Com New (PROF) | 0.2 | $13M | 787k | 16.36 | |
| Treace Med Concepts (TMCI) | 0.1 | $10M | 324k | 31.26 | |
| Cytosorbents Corp Com New (CTSO) | 0.1 | $9.8M | 1.3M | 7.55 | |
| Ayala Pharmaceuticals Incorporated | 0.1 | $6.8M | 668k | 10.19 | |
| Neuronetics (STIM) | 0.1 | $6.3M | 394k | 16.02 | |
| Cabaletta Bio (CABA) | 0.1 | $6.0M | 696k | 8.60 | |
| Xeris Pharmaceuticals | 0.1 | $5.5M | 1.4M | 4.07 | |
| Atea Pharmaceuticals (AVIR) | 0.1 | $5.1M | 237k | 21.48 | |
| Talis Biomedical Corp | 0.1 | $4.0M | 364k | 11.03 | |
| Aprea Therapeutics | 0.1 | $3.4M | 695k | 4.88 | |
| Yumanity Therapeutics | 0.0 | $693k | 60k | 11.65 | |
| Tricida | 0.0 | $237k | 55k | 4.33 | |
| Syros Pharmaceuticals | 0.0 | $212k | 39k | 5.45 | |
| Ovid Therapeutics (OVID) | 0.0 | $159k | 41k | 3.91 |
